140 related articles for article (PubMed ID: 2775505)
21. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
22. Elevation of red cell sodium-lithium countertransport in hyperlipidemias.
Corrocher R; Steinmayr M; Ruzzenente O; Brugnara C; Bertinato L; Mazzi M; Furri C; Bonfanti F; De Sandre G
Life Sci; 1985 Feb; 36(7):649-55. PubMed ID: 3968981
[TBL] [Abstract][Full Text] [Related]
23. Red blood cell Na content, Na, Li-countertransport, family history of hypertension and blood pressure in school children.
Trevisan M; Strazzullo P; Cappuccio FP; Di Muro MR; De Colle S; Franzese A; Iacone R; Krogh V
J Hypertens; 1988 Mar; 6(3):227-30. PubMed ID: 3361120
[TBL] [Abstract][Full Text] [Related]
24. Na+-Li+ countertransport and electrolyte composition in erythrocytes of patients with essential hypertension before and after antihypertensive treatment.
Beuckelmann D; Erdmann E
Klin Wochenschr; 1986 Oct; 64(21):1101-5. PubMed ID: 3807255
[TBL] [Abstract][Full Text] [Related]
25. A kinetic expression for sodium-lithium countertransport in human red cells.
Smith JB; Ash KO; Hentschel WM; Williams RR
Clin Chim Acta; 1982 Jul; 122(3):337-43. PubMed ID: 7105418
[TBL] [Abstract][Full Text] [Related]
26. Peripheral resistance and red cell Li-Na countertransport in borderline hypertensives.
Fujita T; Noda H; Ando K; Sato Y
Life Sci; 1983 Apr; 32(14):1621-7. PubMed ID: 6835006
[TBL] [Abstract][Full Text] [Related]
27. Red cell sodium-lithium countertransport and blood pressure in children with insulin-dependent diabetes mellitus.
Dobos M; Madácsy L; Yasar SA; Breckner M; Körner A; Szücs L; Nagy I; Tulassay T
Diabetes Res Clin Pract; 1994 Nov; 26(1):15-20. PubMed ID: 7875045
[TBL] [Abstract][Full Text] [Related]
28. Sodium-lithium countertransport in erythrocytes of children and adolescents with hypertension.
Norling LL; Goldring D; Hernandez A; Robson AM; Landt M
Dev Pharmacol Ther; 1986; 9(4):231-40. PubMed ID: 3757730
[TBL] [Abstract][Full Text] [Related]
29. Red-cell sodium-lithium countertransport and fractional excretion of lithium in normal and hypertensive humans.
Weinberger MH; Smith JB; Fineberg NS; Luft FC
Hypertension; 1989 Mar; 13(3):206-12. PubMed ID: 2493425
[TBL] [Abstract][Full Text] [Related]
30. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
Siebers RW; Maling TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
[TBL] [Abstract][Full Text] [Related]
31. Heritability of erythrocyte Na+-Li+ countertransport in relation to essential hypertension.
Kagamimori S; Takata M; Naruse Y; Watanabe M; Miyamoto N; Okada A
Clin Exp Hypertens A; 1984; 6(5):951-60. PubMed ID: 6329557
[TBL] [Abstract][Full Text] [Related]
32. [The role of the rate of sodium-lithium countertransport of the erythrocytes in arterial hypertension].
Kobal' AM; Britov AN; Orlov SN; Pokudin NI; Grishenkov EA; Deev AD
Ter Arkh; 1991; 63(12):46-9. PubMed ID: 1803601
[TBL] [Abstract][Full Text] [Related]
33. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
Chen YD; Zheng FL; Wen LR
Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
[TBL] [Abstract][Full Text] [Related]
34. [Erythrocyte Na+/Li+ countertransport and arterial hypertension: data of a cross-sectional population study].
Britov AN; Kobal' AM; Orlov SN; Pokudin NI; Sapozhnikov II; Grishenkov EA
Kardiologiia; 1991 Aug; 31(8):54-8. PubMed ID: 1795476
[TBL] [Abstract][Full Text] [Related]
35. [The relation of arterial pressure and the rate of Na-Li countertransport in a representative subsample of the population of Moscow residents].
Petrov VV; Britov AN; Konstantinov EN; Sviderskiĭ VG; Minchenko BI; Novikov ID; Grishenkov EA; Kaĭkov MI; Levitskiĭ DO
Ter Arkh; 1990; 62(4):81-5. PubMed ID: 2392773
[TBL] [Abstract][Full Text] [Related]
36. Red blood cell lithium-sodium countertransport in the tecumseh blood pressure study.
Weder AB; Schork NJ; Krause L; Julius S
Hypertension; 1991 May; 17(5):652-60. PubMed ID: 2022408
[TBL] [Abstract][Full Text] [Related]
37. Correlates of sodium-lithium countertransport. Findings from the Gubbio Epidemiological Study. The Gubbio Collaborative Study Group.
Trevisan M; Laurenzi M
Circulation; 1991 Nov; 84(5):2011-9. PubMed ID: 1934375
[TBL] [Abstract][Full Text] [Related]
38. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
Lopes de Faria JM; Silveira LA; Morgano M; Pavin EJ; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1482-5. PubMed ID: 10798666
[TBL] [Abstract][Full Text] [Related]
39. Distribution of sodium-lithium countertransport and blood pressure in Caucasians five to eighty-nine years of age.
Turner ST; Weidman WH; Michels VV; Reed TJ; Ormson CL; Fuller T; Sing CF
Hypertension; 1989 Apr; 13(4):378-91. PubMed ID: 2925236
[TBL] [Abstract][Full Text] [Related]
40. Uric acid metabolism and tubular sodium handling. Results from a population-based study.
Cappuccio FP; Strazzullo P; Farinaro E; Trevisan M
JAMA; 1993 Jul; 270(3):354-9. PubMed ID: 8315780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
